0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Nanoplastics Sign in to save

Presence of nanoplastics in sputum of patients with severe asthma: a novel environmental perspective

2025 Score: 48 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Leandro Tapia Barredo, Agnes Hernandez Biette, Paula Gonçalves Romeu, Raquel Guillamat Prats, Jordi Pétriz, Maria-Stella Serrano, Ignasi García-Olivé, Clara Padró, María Basagaña, Antoni Rosell Gratacós, Carlos Martínez‐Rivera

Summary

Researchers analyzed sputum from severe asthma patients and detected nanoplastics in samples for the first time, comparing concentrations and immune profiles across asthma phenotypes. Nanoplastic presence in sputum was associated with more severe disease and distinct immune dysregulation patterns, identifying environmental nanoplastic exposure as a potential modifier of asthma severity.

Studies suggest that environmental exposure to micro-and-nanoplastics (MNPs) may influence asthma pathophysiology given their potential to trigger and maintain immune responses. Evidence is lacking regarding the link between the presence of MNPs and disease severity and phenotypes. We aim to understand their possible role in the immune respose of severe asthma. This cross-section study analyzes the presence of MNPs in sputum samples from patients with severe asthma, classified into allergic T2 (ASA, n=13), non-allergic eosinophilic T2 (ASE, n=11), and non-T2 phenotypes (ASNE, n=8), compared to a healthy control group (n=11). We detected MNPs via spectral flow cytometry with Nile Red staining and MULTIPLEX panel for inflammatory cytokines. We used used ANOVA to determine statistical significance (p<0.05). We found a statistically significant difference between the studied groups and mean MNPs per uL of sputum (F(3, 39)=3.53, p=0.02). Tukey’s HSD test only found significant differences in the mean number of MNPs found in sputum between ASE (76,8, n=11) ASA patients (20,7, n=13)(p=0.03), and ASNE (18, n=8)(p=0.05), but not with control participants (27,4, n=11)(p=0.08). ASE also had significantly increased levels of PDGFB-b (F(3, 29)=7, p=0.001), while no significant difference was estabilshed on the other studied cytokines. The higher concentration of MNPs and PDGFB-b in the ASE phenotype could suggest an interaction between MNPs and airway remodelling and eosinophilic inflammatory pathway in severe asthma. Given the limited number of studies on this topic and our small sample size, further research is needed to understand the exact mechanisms they excert their role in severe asthma.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Cellular and molecular mechanisms of allergic asthma

Researchers reviewed the cellular and molecular mechanisms behind allergic asthma, finding that rising exposure to environmental pollutants — including microplastics — likely contributes to the disease's increasing prevalence, as pollutants disrupt airway barrier integrity and trigger immune responses that lead to chronic airway inflammation.

Article Tier 2

Impact of Microplastic Exposure on Airway Inflammation in an Acute Asthma Murine Model

Mouse experiments found that microplastic exposure worsened inflammatory responses in healthy lungs but did not further aggravate airway inflammation in mice with pre-existing asthma, suggesting the lung's response to microplastics depends on baseline immune state.

Article Tier 2

Airborne micro- and nanoplastics: emerging causes of respiratory diseases

This review examines growing evidence that tiny airborne plastic particles can enter the lungs and trigger or worsen respiratory diseases including asthma, chronic obstructive pulmonary disease, and lung inflammation. The smallest nanoplastics are especially concerning because they can penetrate deep into lung tissue and even enter the bloodstream, yet research on airborne plastic health effects significantly lags behind studies on waterborne exposure.

Article Tier 2

Detrimental effects of microplastic exposure on normal and asthmatic pulmonary physiology

Researchers exposed both healthy and asthmatic mice to airborne microplastics and found significant lung inflammation, immune activation, and increased mucus production in both groups. Microplastic particles were taken up by immune cells called macrophages, and gene analysis revealed changes in immune response, cellular stress, and cell death pathways. The study suggests that inhaling microplastics may worsen respiratory health in both normal and vulnerable populations.

Article Tier 2

Micro- and nanoplastic exposure, immune cell activation, and lung function in young adults, The PIAMA Cohort

Researchers estimated micro- and nanoplastic exposure in young adults and investigated associations with immune cell activation markers and lung function measurements. Higher estimated MNP exposure was associated with elevated inflammatory immune markers and modestly reduced lung function parameters, providing early human epidemiological evidence of respiratory immune effects.

Share this paper